home
Author : adminDate : 2021-12-18 09:00

RegeneRx Joint Venture Will Hold Pre-BLA Meeting with FDA on February 28, 2022

RegeneRx, a clinical-stage drug development company focused on tissue protection, repair and regeneration, today announced that the U.S. 

 

Please refer to the following website for further details: 

https://finance.yahoo.com/news/regenerx-joint-venture-hold-pre-144300569.html?soc_src=social-sh&soc_trk=ma